Search by article title, author,
keywords, and DOI

Tables of Contents» MORE

Volume 69 (2024)
Volume 68 (2023)
Volume 67 (2022)
Volume 66 (2021)
Volume 65 (2020)
Volume 64 (2019)
Volume 63 (2018)
Volume 62 (2017)
Volume 61 (2016)
Volume 60 (2015)
Volume 59 (2014)
Volume 58 (2013)
Volume 57 (2012)
Volume 56 (2011)
Volume 55 (2010)
Volume 54 (2009)
Volume 53 (2008)
Volume 52 (2007)
Volume 51 Number 2 (2006/October)
Volume 51 Number 1 (2006/April)
Volume 50 Number 2 (2005/October)
Volume 50 Number 1 (2005/April)
Volume 49 Number 2 (2004/October)
Volume 49 Number 1 (2004/April)
Volume 48 Number 2 (2003)
Volume 48 Number 1 (2003)
Volume 47 Number 2 (2002/October)
Volume 47 Number 1 (2002/April)
Volume 46 Number 2 (2001/October)
Volume 46 Number 1 (2001/April)
Volume 45 Number 2 (2000/October)
Volume 45 Number 1 (2000/April)
Volume 44 (1999)
Volume 43 Number 2 (1998/October)
Volume 43 Number 1 (1998/April)
Volume 42 (1997/October)
Volume 31-41 (1986-1996)
Volume 21-30 (1976-1985)
Volume 11-20 (1966-1975)
Volume 1-10 (1956-1965)
Call for Papers: Multifaceted interpretation of the legacy of interdisciplinary (Deadline: 06/30/2025)      Welcome to the Journal of NTNU Website     

Journal directory listing - Volume 21-30 (1976-1985) - Volume 29 (1984)
Directory
Back

Synthesis of 2,4-Diamino-6-Substitued Pteridine
Author: Chunfeng Shey, Chao-Tung Chen, Jhy-Ming Horng, Cheng-Hsia Wang

Abstract：

Methotrexate (MTX) is an important anticancer drug widely used in cancer chemotherapy. 2,4-Diamino-6-substitued pteridine (6) is the intermediate for MTX. In this research the intermediate (6) was synthesized from a pyrimidine deri-vative and also from a pyrazire derivative.

《Full Text》